Download PDF
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2019; 16(04): 267-270
DOI: 10.1055/a-1039-5387
Aktuell diskutiert
© Georg Thieme Verlag KG Stuttgart · New York

„Chemobrain“? Beeinträchtigungen kognitiver Funktionen bei Mammakarzinompatientinnen

Kerstin Hermelink
  Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
› Author Affiliations
Further Information

Publication History

Publication Date:
11 December 2019 (online)

Also available at
    Permissions and Reprints

Viele Patientinnen mit einem Mammakarzinom klagen über Beeinträchtigungen des Gedächtnisses, der Aufmerksamkeit und anderer kognitiver Funktionen. Lange Zeit bestand weitgehend Konsens darüber, dass solche Probleme durch die Chemotherapie verursacht werden. Laborexperimente und Tiermodelle fanden Mechanismen, durch die Zytostatika das Gehirn schädigen könnten. Neuere klinische Studien allerdings lassen daran zweifeln, dass das sogenannte Chemobrain überhaupt existiert.
 

  • Literatur

  • 1 Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 2007; 11: 6-15
    CrossrefPubMedGoogle Scholar
  • 2 Habermann B, Carpenter JS. et al. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs 2013; 17: 236-241 . doi:10.1016/j.ejon.2012.06.002
    PubMedGoogle Scholar
  • 3 Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 1995; 4: 61-66
    CrossrefPubMedGoogle Scholar
  • 4 Shilling V, Jenkins V, Trapala IS. The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 2006; 95: 125-129
    CrossrefPubMedGoogle Scholar
  • 5 Pomykala KL, de Ruiter MB, Deprez S. et al. Integrating imaging findings in evaluating the post-chemotherapy brain. Brain Imaging Behav 2013; 7: 436-452 . doi:10.1007/s11682-013-9239-y
    CrossrefPubMedGoogle Scholar
  • 6 Seigers R, Schagen SB, Van Tellingen O. et al. Chemotherapy-related cognitive dysfunction: current animal studies and future directions. Brain Imaging Behav 2013; 7: 453-459 . doi:10.1007/s11682-013-9250-3
    CrossrefPubMedGoogle Scholar
  • 7 Chung NC, Walker AK, Dhillon HM. et al. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies. Oncology (Williston Park) 2018; 32: 591-598
    PubMedGoogle Scholar
  • 8 Ahles TA, Saykin AJ, McDonald BC. et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2008; 110: 143-152
    CrossrefPubMedGoogle Scholar
  • 9 Hermelink K, Voigt V, Kaste J. et al. Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress. J Natl Cancer Inst 2015; 107: djv099 . doi:10.1093/jnci/djv099
    CrossrefPubMedGoogle Scholar
  • 10 Wefel JS, Lenzi R, Theriault R. et al. ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer 2004; 101: 466-475
    CrossrefPubMedGoogle Scholar
  • 11 Hermelink K, Untch M, Lux MP. et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007; 109: 1905-1913
    CrossrefPubMedGoogle Scholar
  • 12 Cimprich B, Reuter-Lorenz P, Nelson J. et al. Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 2010; 32: 324-331 . doi:10.1080/13803390903032537
    CrossrefPubMedGoogle Scholar
  • 13 Scherling C, Collins B, Mackenzie J. et al. Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. J Clin Exp Neuropsychol 2012; 34: 543-560 . doi:10.1080/13803395.2012.666227
    CrossrefPubMedGoogle Scholar
  • 14 Lopez Zunini RA, Scherling C, Wallis N. et al. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study. Brain Imaging Behav 2013; 7: 460-477 . doi:10.1007/s11682-012-9213-0
    CrossrefPubMedGoogle Scholar
  • 15 McDonald BC, Conroy SK, Ahles TA. et al. Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 2012; 30: 2500-2508 . doi:10.1200/JCO.2011.38.5674
    CrossrefPubMedGoogle Scholar
  • 16 Bernstein LJ, McCreath GA, Komeylian Z. et al. Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis. Neurosci Biobehav Rev 2017; 83: 417-428 . doi:10.1016/j.neubiorev.2017.10.028
    CrossrefPubMedGoogle Scholar
  • 17 Ono M, Ogilvie JM, Wilson JS. et al. A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Front Oncol 2015; 5: 59 . doi:10.3389/fonc.2015.00059
    PubMedGoogle Scholar
  • 18 Vearncombe KJ, Rolfe M, Andrew B. et al. Cognitive effects of chemotherapy-induced menopause in breast cancer. Clin Neuropsychol 2011; 25: 1295-1313 . doi:10.1080/13854046.2011.631586
    CrossrefPubMedGoogle Scholar
  • 19 Hermelink K, Henschel V, Untch M. et al. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. Cancer 2008; 113: 2431-2439
    CrossrefPubMedGoogle Scholar
  • 20 Phillips KA, Regan MM, Ribi K. et al. Adjuvant ovarian function suppression and cognitive function in women with breast cancer. Br J Cancer 2016; 114: 956-964 . doi:10.1038/bjc.2016.71
    CrossrefPubMedGoogle Scholar
  • 21 Van Dyk K, Crespi CM, Bower JE. et al. The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment. Cancer 2019; 125: 681-689 . doi:10.1002/cncr.31858
    CrossrefPubMedGoogle Scholar
  • 22 Underwood EA, Rochon PA, Moineddin R. et al. Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Res Treat 2018; 168: 299-310 . doi:10.1007/s10549-017-4627-4
    CrossrefPubMedGoogle Scholar
  • 23 Ahles TA, Hurria A. New Challenges in Psycho-Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions. Psycho-Oncology 2018; 27: 3-9 . doi:10.1002/pon.4564
    PubMedGoogle Scholar
  • 24 Andreotti C, Root JC, Ahles TA. et al. Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline. Psycho-Oncology 2015; 24: 617-623 . doi:10.1002/pon.3683
    CrossrefPubMedGoogle Scholar
  • 25 Bremner JD. Traumatic stress: effects on the brain. Dialogues Clin Neurosci 2006; 8: 445-461
    CrossrefPubMedGoogle Scholar
  • 26 Yang Y, Hendrix CC. Cancer-Related Cognitive Impairment in Breast Cancer Patients: Influences of Psychological Variables. Asia Pac J Oncol Nurs 2018; 5: 296-306 . doi:10.4103/apjon.apjon_16_18
    CrossrefPubMedGoogle Scholar
  • 27 Hermelink K, Buhner M, Sckopke P. et al. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients. J Natl Cancer Inst 2017; 109: djx057 . doi:10.1093/jnci/djx057
    PubMedGoogle Scholar
  • 28 Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv 2018; 12: 537-559 . doi:10.1007/s11764-018-0692-x
    CrossrefPubMedGoogle Scholar
  • 29 Schagen SB, Das E, Vermeulen I. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psycho-Oncology 2012; 21: 1132-1135 . doi:10.1002/pon.2011
    CrossrefPubMedGoogle Scholar